Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients

Annals of Thoracic Surgery

Volumn 78, Issue 4, 2004, Pages 1332-1337

  Ranucci, Marco ^a   Soro, Giorgio ^a   Barzaghi, Nicoletta ^b   Locatelli, Alessandro ^b   Giordano, Gianbeppe ^c   Vavassori, Angelo ^d   Manzato, Aldo ^e   Melchiorri, Chiara ^f   Bove, Tiziana ^g   Juliano, Glauco ^h   Uslenghi, Maria Francesca ^a,i  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b S CROCE E CARLE HOSPITAL   (Italy)

^c Villa Maria Pia Hospital   (Italy)

^d OSPEDALI RIUNITI   (Italy)

^e Cardiac Anesthesia Intensive Care   (Italy)

^f MAURIZIANO HOSPITAL   (Italy)

^g SAN RAFFAELE HOSPITAL   (Italy)

^h CENTRO CARDIOLOGICO MONZINO   (Italy)

ⁱ OSPEDALE DI CIRCOLO   (Italy)

Author keywords

25

Indexed keywords

CATECHOLAMINE; CREATININE; FENOLDOPAM MESILATE;

ACUTE KIDNEY FAILURE; AGED; ANESTHESIA INDUCTION; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; FORWARD HEART FAILURE; HIGH RISK POPULATION; HUMAN; HYPOTHESIS; INCIDENCE; KIDNEY BLOOD FLOW; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SCORING SYSTEM; VASOCONSTRICTION;

AGED; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; COHORT STUDIES; CREATININE; DOPAMINE AGONISTS; FEMALE; FENOLDOPAM; HOSPITAL MORTALITY; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 4644238824     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.02.065     Document Type: Article

References (22)

1. Chertow G.M., Lazarus J.M., Christiansen C.L. Preoperative renal risk stratification. Circulation. 95:1997;878-884
2. Mangano C.M., Diamondstone L.S., Ramsay J.G., Aggarwal A., Hersko A., Mangano D.T. Renal dysfunction after myocardial revascularization risk factors, adverse outcomes, and hospital resources utilization. Ann Intern Med. 128:1998;194-203
3. Ostermann M.E., Taube D., Morgan C.J., Evans T.W. Acute renal failure following cardiopulmonary bypass a changing picture. Intensive Care Med. 26:2000;565-571
4. Conlon P.J., Stafford-Smith M., White W.D., et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant. 14:1999;1158-1162
5. Suen W.S., Mok C.K., Chiu S.W., et al. Risk factors for development of acute renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery. Angiology. 49:1998;789-800
6. Mangos G.J., Brown M.A., Chan W.Y., Horton D., Trew P., Whitworth J.A. Acute renal failure following cardiac surgery incidence, outcomes and risk factors. Aust NZ J Med. 25:1995;284-289
7. Zanardo G., Michielon P., Paccagnella A., et al. Acute renal failure in the patients undergoing cardiac operations. Prevalence, mortality risk, and main risk factors. J Thorac Cardiovasc Surg. 107:1994;1489-1495
8. Ranucci M., Pavesi M., Mazza E., et al. Risk factors for renal dysfunction after coronary surgery the role of cardiopulmonary bypass technique. Perfusion. 9:1994;319-326
9. Swaminathan M., Phillips-Bute B.G., Conlon P.J., Smith P.K., Newman M.F., Stafford-Smith M. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg. 76:2003;784-792
10. Llopart T., Lombardi R., Forselledo M., Andrade R. Acute renal failure in open heart surgery. Renal Fail. 19:1997;319-323
11. White W.B., Halley S.E. Comparative effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension. Arch Intern Med. 149:1989;870-874
12. Elliot W.J., Weber R.R., Nelson K.S., et al. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation. 81:1990;970-977
13. Poinsot G., Romand J.-A., Favre H., Suter P.M. Fenoldopam improves renal hemodynamics impaired by positive end-expiratory pressure. Anesthesiology. 79:1993;680-684
14. Shusterman N.H., Elliot W.J., White W.B. Fenoldopam but not nitroprusside improves renal function in severely hypertensive patients with impaired renal function. Am J Med. 95:1993;161-168
15. Garwood S., Swamidoss C.P., Davis E.A., Samson L., Hines R.L. A case-series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction. J Cardiothorac Vasc Anesth. 17:2003;17-21
16. Caimmi P.P., Pagani L., Micalizzi E., et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 17:2003;491-494
17. National Cardioanesthesia Data Base. Available at: www.ncdb.it
18. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron. 16:1976;31-41
19. Corwin H.L., Sprague S.M., DeLaria G.A., Norusis M.J. Acute renal failure associated with cardiac operations. A case control study. J Thorac Cardiovasc Surg. 98:1989;1107-1112
20. Slogoff S., Reul G.J., Keats A.S., et al. Role of perfusion pressure and flow in major organ dysfunction after cardiopulmonary bypass. Ann Thorac Surg. 50:1990;911-918
21. Kellum J.A., Decker J.M. Use of dopamine in acute renal failure a meta-analysis. Crit Care Med. 29:2001;1526-1531
22. Holmes C.L., Walley K.R. Bad medicine. Low-dose dopamine in the ICU. Chest. 123:2003;1266-1275